Nemat Khan

Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain

Nemat Khan, Andy Kuo, David A. Brockman et al. · Inflammopharmacology · 2017 · 80 citations

Life Sciences, Immunology, Neuroscience +17

Antiallodynic effects of alpha lipoic acid in an optimized <scp>RR</scp>‐<scp>EAE</scp> mouse model of <scp>MS</scp>‐neuropathic pain are accompanied by attenuation of upregulated <scp>BDNF</scp>‐TrkB‐<scp>ERK</scp> signaling in the dorsal horn of the spinal cord

Nemat Khan, Richard D. Gordon, Trent M. Woodruff et al. · Pharmacology Research & Perspectives · 2015 · 39 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods

Nemat Khan, Trent M. Woodruff, Maree T. Smith · Pharmacology Biochemistry and Behavior · 2014 · 38 citations

Life Sciences, Neurology, Neuroscience +16

Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool–Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists

Janice Tiao, Rui Feng, Emily M. Berger et al. · British Journal of Dermatology · 2017 · 33 citations · Full text

Medicine, Dermatology, Neurology +16

The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index ( <scp>CDASI</scp> ) among dermatologists, rheumatologists and neurologists

Janice Tiao, Rui Feng, Steven Bird et al. · British Journal of Dermatology · 2016 · 32 citations · Full text

Medicine, Dermatology, Neurology +14